| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |